Cheng, H., Meng, X., Zhang, Y., Wang, P., & Lu, Y. Identification of CDKN3 overexpression as a marker of poor prognosis and potential therapeutic target in low-grade glioma. Nature Portfolio.
Chicago Style (17th ed.) CitationCheng, Hongbing, Xiao Meng, Yanhua Zhang, Pu Wang, and Yucheng Lu. Identification of CDKN3 Overexpression as a Marker of Poor Prognosis and Potential Therapeutic Target in Low-grade Glioma. Nature Portfolio.
MLA (9th ed.) CitationCheng, Hongbing, et al. Identification of CDKN3 Overexpression as a Marker of Poor Prognosis and Potential Therapeutic Target in Low-grade Glioma. Nature Portfolio.
Warning: These citations may not always be 100% accurate.